Xenon Vision

Company Information
Address One Progress Blvd, #36
Alachua, FL, 32615


Information

DUNS:

# of Employees: N/A


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. NOVEL CAI DERIVATIVES FOR TOPICAL APPLICATION

    Amount: $50,000.00

    IN MORE THAN 50% OF GLAUCOMA PATIENTS INTRAOCULAR PRESSURE (IOP) IS NOT ADEQUATELY CONTROLLED BY SINGLE DRUG THERAPY. OPTIC NERVE DAMAGE ASSOCIATED WITH ELEVATED IOP IS THE LEADING CAUSE OF IRREVERSIB ...

    SBIRPhase I1991Department of Health and Human Services
  2. PILOCARPINE PRODRUGS WITH IMPROVED BIOAVAILABILITY

    Amount: $50,000.00

    INTRAOCULAR PRESSURE (IOP) IS NOT ADEQUATELY CONTROLLED BY SINGLE DRUG THERAPY IN MORE THAN 50 PERCENT OF GLAUCOMA PATIENTS. THE DEVELOPMENT OF ADDITIONAL DRUGS TO TREAT GLAUCOMA EITHER ALONE OR IN CO ...

    SBIRPhase I1990Department of Health and Human Services

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government